It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Dr. Elaine Jones, Board Member of the Novartis Venture Fund

Dr. Elaine Jones


Elaine Jones PhD is an experienced biopharmaceutical executive with more than 20 years of investment experience as a life science-focused venture capitalist. She currently serves on the boards of several public companies, is the Chair of Mironid (UK), and serves as an advisor to InnovateUK, the UK's innovation agency. She was most recently Vice President, Venture Capital at Pfizer Ventures, the corporate venture capital arm of Pfizer, where she was responsible for managing biotechnology and healthcare investments for Pfizer, as well as serving on the boards of directors of several biotech companies. Prior to Pfizer, Dr. Jones was a General Partner with EuclidSR Partners, a venture fund focused on the life sciences and technology sectors, as well as in areas where those industries converge to enhance drug discovery, development and marketing. She began her investing career in 1999 at S.R. One, the corporate investment fund of GlaxoSmithKline. During her venture career, she served on the boards of more than 20 early to mid-stage biotechnology, therapeutic and pharmaceutical companies. Previously, she was the Director of Scientific Licensing at SmithKline Beecham and a research scientist in the research and development division of SmithKline Beecham Pharmaceuticals. Dr. Jones received a BS in Biology from Juniata College, a PhD in Microbiology from the University of Pittsburgh, and conducted postdoctoral research at the National Institutes of Health, in the National Institute of Allergy and Infectious Disease.